search
Back to results

Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC) (ETOC)

Primary Purpose

Respiratory Failure, Cardiovascular Surgery

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Dilatational Percutaneous tracheostomy
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Failure focused on measuring Percutaneous tracheostomy, Endotracheal intubation, Mechanical ventilation, Cardiac surgery, Ventilator-free days

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Are 18 years of age or older Have undergone cardiovascular surgery Are still on invasive mechanical ventilation on day 4 after surgery Have failed the screening test or the spontaneous breathing trial Have signed the informed consent (patient or legal representative) Exclusion Criteria: Age less than18 Pregnant woman Intubation more than 48 hours before cardiovascular surgery More than 5 days on mechanical ventilation after cardiac surgery Artificial heart implantation Concomitant neck surgery (carotid) Previously tracheostomized Major hemorrhagic risk Persistence of platelet count less than 50.000/mm3 after platelet transfusion Prothrombin time less than 30% despite coagulation factors administration Clinical evidence of ongoing infection at the proposed tracheotomy site Anatomical deformity of the neck making risky a tracheostomy Probability of dying the day of randomization defined by SAPSII more than 80 Irreversible neurological lesions Decision of care limitation Prior inclusion in a trial with morbidity-mortality as main judgement criteria Previous enrollment in this trial Consent refusal

Sites / Locations

  • Institut de Cardiologie - Chu Pitie Salpetriere Ap-Hp

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Dilatational Percutaneous tracheostomy

Arm Description

Dilatational Percutaneous tracheostomy

Outcomes

Primary Outcome Measures

Number of ventilator-free days defined as the number of days between successful weaning from MV and day 60 after study enrolment.
VFDs = 0 if the patient dies before 60days.
VFDs= (60- X) : if the patient is successfully weaned from MV within 60 days, where X is the number of days spent receiving MV
VFDs = 0: if the patient requires MV for 60 days or more
The trial will be considered positive if early tracheostomy increases the number VFDs of at least 7 days (mean)

Secondary Outcome Measures

Other outcomes will be compared between the two arms:
Mortality rate (day 60, in-ICU, in-hospital)
ICU length of stay
Hospital length of stay
Duration of MV in survivors
Organ failure evolution
Infectious complications
Early laryngeal and tracheal complications
Sedation needs
Patient comfort
Outcome on day 90

Full Information

First Posted
June 29, 2006
Last Updated
December 2, 2009
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France
search

1. Study Identification

Unique Protocol Identification Number
NCT00347321
Brief Title
Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)
Acronym
ETOC
Official Title
Evaluation of Early Percutaneous Tracheostomy in Patients Undergoing Cardiovascular Surgery and Requiring Prolonged Mechanical Ventilation
Study Type
Interventional

2. Study Status

Record Verification Date
March 2007
Overall Recruitment Status
Completed
Study Start Date
July 2006 (undefined)
Primary Completion Date
March 2009 (Actual)
Study Completion Date
June 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a phase III clinical trial comparing early tracheostomy (day 4) versus prolonged endotracheal intubation in ICU patients needing prolonged ventilatory support after cardiovascular surgery.
Detailed Description
Background: Prolonged mechanical ventilation (MV> 7 days) is required in less than 10% of patients after cardiovascular surgery but it is associated with high morbidity and mortality. Several studies conducted in critically ill patients suggested that early percutaneous tracheotomy compared with delayed tracheotomy decreases the length of ventilator dependence and improves outcome. To date, no randomized trial has tested these possible benefits in critically ill patients after cardiac surgery. Study objectives: A randomized trial has been designed to determine whether early tracheostomy (day 4 after cardiac surgery) in patients still on MV would reduce the number of days under MV, measured by the evaluation of ventilator-free days (VFDs). Secondary objectives are the reduction of mortality, reduction of ICU and hospital length of stay. Evaluation of organ failure evolution, infectious complications, sedation needs, patient comfort and outcome at 3 months will be also considered. Study hypothesis: The trial will be consider positive if early tracheotomy increases the number VFDs of at least 7 days (mean) evaluated on day 60 after randomisation. Methods : Trial : randomized, open, controlled, monocentric Inclusion criteria: see columns below Exclusion criteria: see columns below Randomization: will use a computerised system on day 4 after cardiac surgery Procedures: see columns below Recorded data: demographic characteristics, pre, per and postoperative parameters. From randomization until ICU discharge (or day 60), a daily chart will be completed. Judgment criteria: see columns below Sample size and statistical analysis: using Wilcoxon bilateral test with an alpha risk of 5% and a power of 80%, we calculated that 108 patients in each arm would be needed. Statistical analyses will use standard tests to compare population of the two arms.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Failure, Cardiovascular Surgery
Keywords
Percutaneous tracheostomy, Endotracheal intubation, Mechanical ventilation, Cardiac surgery, Ventilator-free days

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
212 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dilatational Percutaneous tracheostomy
Arm Type
Experimental
Arm Description
Dilatational Percutaneous tracheostomy
Intervention Type
Procedure
Intervention Name(s)
Dilatational Percutaneous tracheostomy
Intervention Description
Dilatational Percutaneous tracheostomy
Primary Outcome Measure Information:
Title
Number of ventilator-free days defined as the number of days between successful weaning from MV and day 60 after study enrolment.
Time Frame
between successful weaning from MV and day 60 after study enrolment.
Title
VFDs = 0 if the patient dies before 60days.
Time Frame
before 60 days
Title
VFDs= (60- X) : if the patient is successfully weaned from MV within 60 days, where X is the number of days spent receiving MV
Time Frame
during 60 days
Title
VFDs = 0: if the patient requires MV for 60 days or more
Time Frame
during 60 days and after
Title
The trial will be considered positive if early tracheostomy increases the number VFDs of at least 7 days (mean)
Time Frame
at 7 days
Secondary Outcome Measure Information:
Title
Other outcomes will be compared between the two arms:
Time Frame
during the trial
Title
Mortality rate (day 60, in-ICU, in-hospital)
Time Frame
during the 60 days
Title
ICU length of stay
Time Frame
during the trial
Title
Hospital length of stay
Time Frame
during the trial
Title
Duration of MV in survivors
Time Frame
during the trial
Title
Organ failure evolution
Time Frame
during the trial
Title
Infectious complications
Time Frame
during the trial
Title
Early laryngeal and tracheal complications
Time Frame
during the trial
Title
Sedation needs
Time Frame
during the trial
Title
Patient comfort
Time Frame
during the trial
Title
Outcome on day 90
Time Frame
to 90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Are 18 years of age or older Have undergone cardiovascular surgery Are still on invasive mechanical ventilation on day 4 after surgery Have failed the screening test or the spontaneous breathing trial Have signed the informed consent (patient or legal representative) Exclusion Criteria: Age less than18 Pregnant woman Intubation more than 48 hours before cardiovascular surgery More than 5 days on mechanical ventilation after cardiac surgery Artificial heart implantation Concomitant neck surgery (carotid) Previously tracheostomized Major hemorrhagic risk Persistence of platelet count less than 50.000/mm3 after platelet transfusion Prothrombin time less than 30% despite coagulation factors administration Clinical evidence of ongoing infection at the proposed tracheotomy site Anatomical deformity of the neck making risky a tracheostomy Probability of dying the day of randomization defined by SAPSII more than 80 Irreversible neurological lesions Decision of care limitation Prior inclusion in a trial with morbidity-mortality as main judgement criteria Previous enrollment in this trial Consent refusal
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean Louis TROUILLET, MD,
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut de Cardiologie - Chu Pitie Salpetriere Ap-Hp
City
Paris
ZIP/Postal Code
75013
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
21403073
Citation
Trouillet JL, Luyt CE, Guiguet M, Ouattara A, Vaissier E, Makri R, Nieszkowska A, Leprince P, Pavie A, Chastre J, Combes A. Early percutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery: a randomized trial. Ann Intern Med. 2011 Mar 15;154(6):373-83. doi: 10.7326/0003-4819-154-6-201103150-00002.
Results Reference
derived

Learn more about this trial

Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)

We'll reach out to this number within 24 hrs